{"id":"https://openalex.org/W2465577901","doi":null,"title":"Akt1 overexpression in HER2/neu positive breast tumors in African American and Latina women may contribute to poor disease free and overall survival","display_name":"Akt1 overexpression in HER2/neu positive breast tumors in African American and Latina women may contribute to poor disease free and overall survival","publication_year":2007,"publication_date":"2007-11-01","ids":{"openalex":"https://openalex.org/W2465577901","mag":"2465577901"},"language":"en","primary_location":{"id":"mag:2465577901","doi":null,"is_oa":false,"landing_page_url":"http://cebp.aacrjournals.org/content/16/11_Supplement/B104","pdf_url":null,"source":{"id":"https://openalex.org/S2764672815","display_name":"Cancer Epidemiology and Prevention Biomarkers","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Cancer Epidemiology and Prevention Biomarkers","raw_type":null},"volume":null,"type":"article","indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5020933664","display_name":"Yanyuan Wu","orcid":"https://orcid.org/0000-0003-0286-1800","observed_orcids":["https://orcid.org/0000-0003-0286-1800"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]},{"id":"https://openalex.org/I52710748","display_name":"Charles R. Drew University of Medicine and Science","ror":"https://ror.org/038x2fh14","country_code":"US","type":"education","lineage":["https://openalex.org/I52710748"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yanyuan Wu","raw_affiliation_strings":["Charles R. Drew Univ. of Medicine & Sci., Los Angeles, CA, David Geffen UCLA School of Medicine, Los Angeles, CA"],"raw_orcid":"https://orcid.org/0000-0003-0286-1800","affiliations":[{"raw_affiliation_string":"Charles R. Drew Univ. of Medicine & Sci., Los Angeles, CA, David Geffen UCLA School of Medicine, Los Angeles, CA","institution_ids":["https://openalex.org/I161318765","https://openalex.org/I52710748"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049083118","display_name":"Hezla Mohammed","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]},{"id":"https://openalex.org/I52710748","display_name":"Charles R. Drew University of Medicine and Science","ror":"https://ror.org/038x2fh14","country_code":"US","type":"education","lineage":["https://openalex.org/I52710748"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hezla Mohammed","raw_affiliation_strings":["Charles R. Drew Univ. of Medicine & Sci., Los Angeles, CA, David Geffen UCLA School of Medicine, Los Angeles, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Charles R. Drew Univ. of Medicine & Sci., Los Angeles, CA, David Geffen UCLA School of Medicine, Los Angeles, CA","institution_ids":["https://openalex.org/I161318765","https://openalex.org/I52710748"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110153602","display_name":"Ram K. Chillar","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]},{"id":"https://openalex.org/I52710748","display_name":"Charles R. Drew University of Medicine and Science","ror":"https://ror.org/038x2fh14","country_code":"US","type":"education","lineage":["https://openalex.org/I52710748"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ram Chillar","raw_affiliation_strings":["Charles R. Drew Univ. of Medicine & Sci., Los Angeles, CA, David Geffen UCLA School of Medicine, Los Angeles, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Charles R. Drew Univ. of Medicine & Sci., Los Angeles, CA, David Geffen UCLA School of Medicine, Los Angeles, CA","institution_ids":["https://openalex.org/I161318765","https://openalex.org/I52710748"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007496757","display_name":"Ishrat Ali","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]},{"id":"https://openalex.org/I52710748","display_name":"Charles R. Drew University of Medicine and Science","ror":"https://ror.org/038x2fh14","country_code":"US","type":"education","lineage":["https://openalex.org/I52710748"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ishrat Ali","raw_affiliation_strings":["Charles R. Drew Univ. of Medicine & Sci., Los Angeles, CA, David Geffen UCLA School of Medicine, Los Angeles, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Charles R. Drew Univ. of Medicine & Sci., Los Angeles, CA, David Geffen UCLA School of Medicine, Los Angeles, CA","institution_ids":["https://openalex.org/I161318765","https://openalex.org/I52710748"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Sheila Clayton","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]},{"id":"https://openalex.org/I52710748","display_name":"Charles R. Drew University of Medicine and Science","ror":"https://ror.org/038x2fh14","country_code":"US","type":"education","lineage":["https://openalex.org/I52710748"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sheila Clayton","raw_affiliation_strings":["Charles R. Drew Univ. of Medicine & Sci., Los Angeles, CA, David Geffen UCLA School of Medicine, Los Angeles, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Charles R. Drew Univ. of Medicine & Sci., Los Angeles, CA, David Geffen UCLA School of Medicine, Los Angeles, CA","institution_ids":["https://openalex.org/I161318765","https://openalex.org/I52710748"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015491002","display_name":"Dennis J. Slamon","orcid":"https://orcid.org/0000-0002-6330-498X","observed_orcids":["https://orcid.org/0000-0002-6330-498X"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]},{"id":"https://openalex.org/I52710748","display_name":"Charles R. Drew University of Medicine and Science","ror":"https://ror.org/038x2fh14","country_code":"US","type":"education","lineage":["https://openalex.org/I52710748"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Dennis J. Slamon","raw_affiliation_strings":["Charles R. Drew Univ. of Medicine & Sci., Los Angeles, CA, David Geffen UCLA School of Medicine, Los Angeles, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Charles R. Drew Univ. of Medicine & Sci., Los Angeles, CA, David Geffen UCLA School of Medicine, Los Angeles, CA","institution_ids":["https://openalex.org/I161318765","https://openalex.org/I52710748"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5012585441","display_name":"Jaydutt V. Vadgama","orcid":"https://orcid.org/0000-0002-0019-8622","observed_orcids":["https://orcid.org/0000-0002-0019-8622"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]},{"id":"https://openalex.org/I52710748","display_name":"Charles R. Drew University of Medicine and Science","ror":"https://ror.org/038x2fh14","country_code":"US","type":"education","lineage":["https://openalex.org/I52710748"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jaydutt V. Vadgama","raw_affiliation_strings":["Charles R. Drew Univ. of Medicine & Sci., Los Angeles, CA, David Geffen UCLA School of Medicine, Los Angeles, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Charles R. Drew Univ. of Medicine & Sci., Los Angeles, CA, David Geffen UCLA School of Medicine, Los Angeles, CA","institution_ids":["https://openalex.org/I161318765","https://openalex.org/I52710748"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.35570779,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"16","issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.8773999810218811,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.8773999810218811,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.06030000001192093,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","score":0.04690000042319298,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/akt-activation","display_name":"Akt activation","score":0.5400000214576721},{"id":"https://openalex.org/keywords/her2-overexpression","display_name":"HER2 overexpression","score":0.9729999899864197},{"id":"https://openalex.org/keywords/breast-cancer","display_name":"breast cancer","score":0.9829999804496765},{"id":"https://openalex.org/keywords/african-american-women","display_name":"African American women","score":0.984000027179718},{"id":"https://openalex.org/keywords/hispanic-women","display_name":"Hispanic women","score":0.9959999918937683},{"id":"https://openalex.org/keywords/disease-free-survival","display_name":"disease-free survival","score":0.9380000233650208},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.9950000047683716},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.7480000257492065},{"id":"https://openalex.org/keywords/pi3k-akt-signaling","display_name":"PI3K/Akt signaling","score":0.871999979019165},{"id":"https://openalex.org/keywords/estrogen-receptor-negative","display_name":"estrogen receptor-negative","score":0.453000009059906},{"id":"https://openalex.org/keywords/progesterone-receptor-negative","display_name":"progesterone receptor-negative","score":0.9890000224113464},{"id":"https://openalex.org/keywords/lymph-node-metastasis","display_name":"lymph node metastasis","score":0.9409999847412109},{"id":"https://openalex.org/keywords/tamoxifen-response","display_name":"tamoxifen response","score":0.9190000295639038},{"id":"https://openalex.org/keywords/chemotherapy-response","display_name":"chemotherapy response","score":0.9150000214576721},{"id":"https://openalex.org/keywords/breast-cancer-recurrence","display_name":"breast cancer recurrence","score":0.7599999904632568}],"concepts":[{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.7624685764312744},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6993873715400696},{"id":"https://openalex.org/C204232928","wikidata":"https://www.wikidata.org/wiki/Q899285","display_name":"Immunohistochemistry","level":2,"score":0.6127254366874695},{"id":"https://openalex.org/C2777176818","wikidata":"https://www.wikidata.org/wiki/Q412178","display_name":"Tamoxifen","level":4,"score":0.5680823922157288},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5623403191566467},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5460607409477234},{"id":"https://openalex.org/C2776872082","wikidata":"https://www.wikidata.org/wiki/Q181874","display_name":"HER2/neu","level":4,"score":0.5312903523445129},{"id":"https://openalex.org/C75217442","wikidata":"https://www.wikidata.org/wiki/Q423650","display_name":"Protein kinase B","level":3,"score":0.5136222243309021},{"id":"https://openalex.org/C2779786085","wikidata":"https://www.wikidata.org/wiki/Q412616","display_name":"Trastuzumab","level":4,"score":0.5135243535041809},{"id":"https://openalex.org/C84606932","wikidata":"https://www.wikidata.org/wiki/Q416496","display_name":"Estrogen receptor","level":4,"score":0.4865674078464508},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3656148314476013},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3631282448768616},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.1721801459789276},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.1409296691417694},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:2465577901","doi":null,"is_oa":false,"landing_page_url":"http://cebp.aacrjournals.org/content/16/11_Supplement/B104","pdf_url":null,"source":{"id":"https://openalex.org/S2764672815","display_name":"Cancer Epidemiology and Prevention Biomarkers","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Cancer Epidemiology and Prevention Biomarkers","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1987328581","https://openalex.org/W2049475256","https://openalex.org/W2339503336","https://openalex.org/W2093219478","https://openalex.org/W2050683019","https://openalex.org/W2009318922","https://openalex.org/W2008954677","https://openalex.org/W2058720172","https://openalex.org/W2029406281","https://openalex.org/W2090631044"],"abstract_inverted_index":{"B104":[0],"Breast":[2],"cancer":[3,49,257,271],"patients":[4,79,117,208],"with":[5,80,155,187,203],"HER2/neu":[6,28,83,101,140,144,169,188,224,254],"overexpressing":[7,29],"tumors":[8,31,73,146],"have":[9,42,89],"a":[10,43,265],"decrease":[11],"in":[12,33,71,166,182,222,249],"disease":[13,172],"free":[14,173],"survival":[15,174],"and":[16,36,53,77,86,102,115,142,147,190,226,236],"overall":[17],"survival.":[18],"It":[19],"remains":[20],"to":[21,51,62,168,212],"be":[22,247,264],"understood,":[23],"what":[24],"the":[25,64,94,100,151,230,253],"etilology":[26],"of":[27,58,67,93,138,162,199,217,261],"breast":[30,48,72,195,256,270],"is":[32,61],"African":[34,75,113],"American":[35,76,114],"Latina":[37,78,116],"women.":[38,55],"These":[39,207],"groups":[40],"generally":[41],"poorer":[44],"outcome":[45],"from":[46,74],"their":[47],"compared":[50],"Caucasian":[52],"Asian":[54],"The":[56,159,197,259],"purpose":[57],"this":[59,122],"study":[60,152],"understand":[63],"clinical":[65],"significance":[66],"activated":[68,163],"Akt":[69,165,200,218],"expression":[70],"corresponding":[81],"tissue":[82,126,131,164],"over-expression.":[84],"Cellular":[85],"molecular":[87],"studies":[88],"shown":[90],"that":[91,180,244],"activation":[92,198],"cell":[95,108],"signaling":[96],"PI3-kinase/Akt":[97],"cascade":[98],"via":[99],"other":[103],"receptor":[104,192],"tyrosine":[105],"kinases":[106],"induce":[107],"proliferation.":[109],"A":[110],"total":[111],"234":[112],"were":[118,128,209],"selected":[119],"retrospectively.":[120],"From":[121],"group,":[123],"120":[124],"tumor":[125,250],"samples":[127],"analyzed":[129],"for":[130,171,269],"pAkt":[132,183,262],"by":[133],"immunohistochemistry.":[134],"This":[135],"cohort":[136],"consisted":[137],"59":[139],"positive":[141,189,204,225],"61":[143],"negative":[145,194,227],"these":[148],"numbers":[149],"gave":[150],"80%":[153],"power":[154],"95%":[156],"confidence":[157],"limit.":[158],"predictive":[160],"value":[161],"relation":[167],"over-expression":[170,260],"was":[175,184,201,232],"determined.":[176],"Our":[177],"results":[178],"demonstrate":[179],"increase":[181],"significantly":[185,219],"associated":[186,202],"estrogen/progesterone":[191],"(ER/PR)":[193],"tumor.":[196],"lymph":[205],"nodes.":[206],"less":[210],"responsive":[211],"tamoxifen":[213],"and/or":[214],"chemotherapy.":[215],"Activation":[216],"reduced":[220],"DFS":[221,231],"both":[223],"groups.":[228,238],"However,":[229],"similar":[233],"between":[234],"HER2/neu-positive/pAkt-negative":[235],"HER2/neu-negativer/pAkt-positve":[237],"In":[239],"summary,":[240],"our":[241],"data":[242],"suggest":[243],"there":[245],"may":[246,263],"differences":[248],"phenotypes":[251],"within":[252],"over-expressing":[255],"patients.":[258],"powerful":[266],"prognostic":[267],"marker":[268],"relapse.":[272]},"counts_by_year":[],"updated_date":"2026-09-29T14:09:16.559479","created_date":"2016-07-22T00:00:00"}